US appeals court revives private lawsuits linking Tylenol to autism, ADHD
13/07/2026 15:34
US appeals court revives private lawsuits linking Tylenol to autism, ADHD NEW YORK, July 13 (Reuters) - A federal appeals court on Monday revived hundreds of private lawsuits against Kenvue KVUE.N and many pharmacies and retailers, alleging that the Tylenol painkiller causes autism and attention deficit hyperactivity order.
The 2nd U.S. Circuit Court of Appeals in Manhattan said a district court judge improperly excluded testimony from expert witnesses offered by parents who sued over their use of Tylenol, or its active ingredient acetaminophen, during pregnancy.
(Reporting by Jonathan Stempel in New York; Editing by Chizu Nomiyama)
((jon.stempel@thomsonreuters.com ; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net /))
Recent news on Kenvue
See all newsBrief: Kenvue To Announce Third Quarter 2026 Results On October 30, 2026
Brief: Kimberly-Clark Corporation Announces Pricing Of $4.9 Billion Private Offering Of Senior Notes
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Media: Kimberly-Clark offers bonds to help fund Kenvue takeover - Bloomberg News
US stocks weekly: AI unwind